Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-McDonald's, Apple, Model N, Neurocrine, HD Supply, AMD

Tue, 10th Sep 2013 12:29

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

Sept. 10 (Reuters) - Some U.S. stocks to watch on Tuesday:

FUTURES CLIMB ON ROSY CHINA DATA, EASING SYRIA FEARS

U.S. stock index futures rose, putting the S&P 500 on trackfor a sixth day of gains, following another batch of rosyeconomic data out of China and as expectations eased about aWestern military strike against Syria. S&P 500 futures were up 0.65 percent, Dow Jones industrial average futures were up 0.62 percent, and Nasdaq 100 futures wereup 0.7 percent.

** APPLE INC, Monday close $506.17, up 0.5 pctpremarket

Apple is expected to introduce a cheaper version of theiPhone on Tuesday, bringing one of the industry's costliestsmartphones within reach of the masses in poorer emergingmarkets.

** MCDONALD'S CORP, Monday close $96.45, up 1 pctpremarket

The fast food chain reported a better-than-expected 1.9percent rise in global sales at established restaurants inAugust, boosted by stronger sales in Europe.

** ADVANCED MICRO DEVICES INC, Monday close $3.69,up 2 pct premarket

The chipmaker, targeting new markets as personal computersales decline, unveiled chips designed to run slot machines,factory robots, airport signs, medical equipment and otherdevices.

** MODEL N INC, Monday close $14.73, down 38 pctpremarket

The revenue management software maker forecast revenue forthe year ending September 2014 below analysts' estimates onMonday. Raymond James, Stifel Nicolaus and JPMorgan cut their ratings on the stock on Tuesday.

Analysts at Stifel said the company did not clearlyarticulate a plan to cut expenses. Raymond James analysts said areturn to revenue growth could be delayed well into 2015 unlessthe company quickly improved sales execution.

** NEUROCRINE BIOSCIENCES INC, Monday close $16.70,down 28 pct premarket

The company said on Monday that a lower dose of itsexperimental drug to treat a rare movement disorder did not meetthe main goal of a mid-stage clinical study. Cowen and Co cut its price target on the stock to $19 from $20while MKM Partners cut its target to $13.50 from $17.00 andOppenheimer to $15 from $19.

** HD SUPPLY HOLDINGS INC, Monday close $24.74, down9.5 pct premarket

The construction products supplier reported a widerquarterly loss for the second quarter due to expenses associatedwith debt restructuring. The company also forecast fiscal 2013results below analysts' estimates.

** STARWOOD PROPERTY TRUST INC, Monday close$25.04, down 4 pct premarket

The company, which finances and manages commercial mortgageloans, said it was offering 25 million shares in an underwrittenpublic offering.

** L&L ENERGY INC, Monday close $2.89, up 15 pctafter market

The coal miner's first-quarter profit more than doubled asproduction was boosted by the acquisition of two mines in Chinain November. Production rose 54 percent to 228,000 tons in thequarter.

** FIVE BELOW INC, Monday close $41.04, up 14 pctafter market

The specialty value retailer reported better-than-expectedresults for the second quarter due to a 6.6 percent increase insame-store sales. The company also raised its full-year earningsand revenue forecast.

** PVH CORP, Monday close $132.11, down 4.4 pctafter market

The maker of Calvin Klein and Tommy Hilfiger clothes gave athird-quarter sales and profit forecast that was below analysts'estimates. The company characterized the global environment as"challenging".

** BLACKBERRY LTD, Monday close $11.53, down 4 pctpremarket

The Canadian company's biggest shareholder has approachedseveral large Canadian investment funds about forging a deal totake the smartphone maker private, but the proposal is still "anairy-fairy, 'what if' kind of thing," according to a source withdirect knowledge of the situation.

** GLAXOSMITHKLINE PLC, Monday close $50.46, down 1pct premarket

The threat of generic copies of the company's best-sellinglung drug Advair finally making it to the market in the UnitedStates hit confidence in the drugmaker.

** MICROSOFT CORP, Monday close $31.65, up 1 pctpremarket

At least three of the top 20 investors in the company want aturnaround expert to succeed Steve Ballmer as chief executive.They have urged the technology giant's board to consider FordMotor Co Chief Executive Alan Mulally and ComputerSciences Corp Chief Executive Mike Lawrie for the job,several sources familiar with the matter said. (Compiled by Varun Aggarwal; Editing by Kirti Pandey)

More News
3 May 2023 09:19

Haleon not surprised by Pfizer stake sale plans, says CFO

LONDON, May 3 (Reuters) - Pfizer's plan to sell its Haleon stake is not a surprise, the consumer health company's finance chief Tobias Hestler told Reuters on Wednesday.

Read more
3 May 2023 07:09

Haleon Q1 profit misses analyst expectations

LONDON, May 3 (Reuters) - Haleon, the world's biggest standalone consumer health business, on Wednesday reported first-quarter profit below analyst expectations.

Read more
29 Apr 2023 15:45

US FDA panel backs restricted use of AstraZeneca's prostate cancer drug

April 28 (Reuters) - A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc's experimental treatment, jointly developed with Merck & Co, for a type of prostate cancer.

Read more
27 Apr 2023 10:39

GSK gets positive EU opinion for respiratory syncytial virus vaccine

(Alliance News) - GSK PLC on Thursday said its respiratory syncytial virus vaccine candidate has gained positive opinion from the European Medicines Agency body.

Read more
27 Apr 2023 10:39

IN BRIEF: Schroders taps PwC exec as CFO, GSK CFO as non-exec director

Schroders PLC - London-based investment manager - Hires Richard Oldfield to succeed Richard Keers as chief financial officer and an executive director. Oldfield currently is vice chair & global markets leader at accountants PricewaterhouseCoopers. Oldfield will join Schroders on October 2, and Keers will depart on December 31 after 10 years with the company. At Schroders, Oldfield will be responsible for "firm-wide operations" and for "financial management, risk management, technology, capital and treasury".

Read more
27 Apr 2023 08:16

EMA adopts 'positive opinion' of GSK's RSV vaccine candidate

(Sharecast News) - GSK updated the market on its respiratory syncytial virus (RSV) vaccine candidate for older adults on Thursday, reporting that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) had adopted a positive opinion by consensus.

Read more
26 Apr 2023 20:21

GSK's RSV vaccine first to get EU regulator's nod

EMA recommends authorization of first RSV vaccine

*

Read more
26 Apr 2023 17:48

European shares fall as healthcare stocks hit by drug reforms

Healthcare index marks biggest decline in 15 months

*

Read more
26 Apr 2023 17:03

LONDON MARKET CLOSE: Tech shines but tepid trade elsewhere

(Alliance News) - European equities closed lower on Wednesday, with lingering banking sector worries hurting sentiment, while tech stocks outperformed wider markets in New York after well-received earnings overnight.

Read more
26 Apr 2023 15:52

UK shareholder meetings calendar - next 7 days

Thursday 27 April 
Admiral Group PLCAGM
AFC Energy PLCAGM
Alliance Trust PLCAGM
AstraZeneca PLCAGM
BP PLCAGM
CLS Holdings PLCAGM
CRH PLCAGM
Dalata Hotel Group PLCAGM
Dial Square Investments PLCAGM
F&C Investment Trust PLCAGM
Flutter Entertainment PLCAGM
Gresham House Renewable Energy VCT 1 PLCAGM
Gresham House Renewable Energy VCT 2 PLCAGM
Helios Towers PLCAGM
Ibstock PLCAGM
International Personal Finance PLCAGM
Kerry Group PLCAGM
London Stock Exchange Group PLCAGM
Pershing Square Holdings LtdAGM
Quixant PLCAGM
Robert Walters PLCAGM
Schroders PLCAGM
Serco Group PLCAGM
STV Group PLCAGM
Synectics PLCAGM
Taylor Wimpey PLCAGM
Tissue Regenix Group PLCAGM
Weir Group PLCAGM
Friday 28 April 
AQRU PLCAGM
Audioboom Group PLCAGM
BBGI Global Infrastructure SAAGM
Everest Global PLCAGM
GetBusy PLCAGM
Greencoat Renewables PLCAGM
Greencoat UK Wind PLCAGM
Hikma Pharmaceuticals PLCAGM
JPMorgan Claverhouse Investment Trust PLCAGM
Kingspan Group PLCAGM
Minoan Group PLCAGM
Pearson PLCAGM
Rotork PLCAGM
Shanta Gold LtdAGM
Smurfit Kappa Group PLCAGM
Symphony International Holdings LtdAGM
Monday 1 May 
no events scheduled 
Tuesday 2 May 
Carr's Group PLCGM re annual report and directors remuneration report
CVC Income & Growth LtdAGM
IOG PLCAGM
Ocado Group PLCAGM
Plus500 LtdAGM
Wednesday 3 May 
Apax Global Alpha LtdAGM
Barclays PLCAGM
GSK PLCAGM
Hyve Group PLCCourt meeting & GM re acquisition by Heron UK Bidco Ltd
Logistics Development Group PLCAGM
Okyo Pharma LtdGM re proposed cancellation of the ordinary shares of no par value
Reach PLCAGM
Reckitt Benckiser Group PLCAGM
Standard Chartered PLCAGM
Tritax Big Box REIT PLCAGM
Unilever PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2023 14:12

EU publishes proposed drug laws overhaul, seting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 13:24

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results thanks to strong sales of its vaccines as well as HIV and respiratory medicines.

Read more
26 Apr 2023 12:03

EU publishes proposed drug laws overhaul, setting up tussle with industry

Reforms will be biggest changes to EU's medical laws in 20 years

*

Read more
26 Apr 2023 09:21

GSK stays strong as healthy sales beat expectations

LONDON, April 26 (Reuters) - GSK began 2023 with a quarterly performance that beat analyst expectations and extended a series of positive results following strong sales of its roster of vaccines as well as HIV and respiratory medicines.

Read more
26 Apr 2023 09:00

TOP NEWS: GSK quarterly sales and profit slips; confirms outlook

(Alliance News) - Brentford, London-based GSK PLC on Wednesday reported a slip in quarterly sales, but confirmed its 2023 guidance.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.